Is nuclear power or renewable energy the key to a zero-carbon future? Explore costs, risks, and global trends shaping the ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Meanwhile, tech power —AI, biotech, quantum, drones, and more—is fundamentally transforming our economy, security, and the very nature of global power. The Trump administration can seize on the ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...